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Abstract
Background: The current concept of overweight/obesity is most likely related to a combination of increased caloric
intake and decreased energy expenditure. Widespread inflammation, associated with both conditions, appears to
contribute to the development of some obesity-related comorbidities. Interventions that directly or indirectly target
individuals at high risk of developing obesity have been largely proposed because of the increasing number of
overweight/obese cases worldwide. The aim of the present study was to assess CXCL16, IL-17, and BMP-2 plasma
factors in middle-aged and elderly women and relate them to an overweight or obese status. In total, 117 women
were selected and grouped as eutrophic, overweight, and obese, according to anthropometric parameters. Analyses
of anthropometric and circulating biochemical parameters were followed by plasma immunoassays for CXCL-16, IL-
17, and BMP-2.
Results: Plasma mediators increased in all overweight and obese individuals, with the exception of BMP-2 in the
elderly group, whereas CXCL16 levels were shown to differentiate overweight and obese individuals. Overweight
and/or obese middle-aged and elderly individuals presented with high LDL, triglycerides, and glycemia levels.
Anthropometric parameters indicating increased-cardiovascular risk were positively correlated with CXCL-16, BMP-2,
and IL-17 levels in overweight and obese middle-aged and elderly individuals.
Conclusion: This study provides evidence that CXCL-16, IL-17, and BMP-2 are potential plasma indicators of
inflammatory status in middle-aged and elderly women; therefore, further investigation of obesity-related
comorbidities is recommended. CXCL16, in particular, could be a potential marker for middle-aged and elderly
individuals transitioning from eutrophic to overweight body types, which represents an asymptomatic and
dangerous condition.
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Background
Obesity is a worldwide epidemic and pathological condi-
tion resulting from contemporary lifestyles; it is charac-
terized by lack of physical activity in addition to an
energy-dense diet [1]. Adipose tissue was previously
defined as a simple energy source used to manage
energy flow in the body; however, it has taken on the
integrative role of linking bioactive mediator release,
homeostasis, and pathological conditions [2]. At least 24
typical inflammatory mediators such as leptin, resistin,
IL-6, TNF, and chemokines, among others (e.g., C-
reactive protein, haptoglobin, and amyloid A) are upreg-
ulated during obesity [3–5].
Natural ageing is currently associated with senescent
immune remodeling, which occurs when innate barriers
lose their abilities to restrict pathogen entry; in this con-
dition, the internal organs become more vulnerable to
metabolic disturbances resulting in a natural reduction
in life expectancy [6, 7]. It is currently accepted that in-
creased visceral omental, not abdominal subcutaneous
adipose tissue, correlates the most with cardiovascular
diseases, insulin resistance, and other obesity-related dis-
eases [8, 9]. Overweight and obesity statuses often start
early in child- or adulthood. These conditions become
detrimental during senescence, when the human body
requires balance to deal with age-associated changes.
Accordingly, lifestyle and nutritional changes in infants
and adults might prevent or postpone some adverse
effects on the immune system and improve quality of life
in elderly individuals. Both the inflammatory context
and biological aging are crucial interrelated components
of the understanding the association of clinical distur-
bances with overweight and obesity.
Based on the many potential biomarkers that have the
capacity to predict obesity- and overweight-related
diseases, we investigated the clinical role of three soluble
mediators in human cardiac and metabolic diseases: (i)
IL-17, a pro-inflammatory cytokine previously associated
with obesity due to its role in the development of
atherosclerosis, coronary syndromes, and glucose toler-
ance [10, 11], (ii) CXCL16, an interferon-gamma-
regulated chemokine and scavenger receptor for oxi-
dized low-density lipoprotein that is expressed in athero-
sclerotic lesions and described as a marker of acute
coronary syndromes [12, 13], and finally, (iii) bone mor-
phogenetic protein-2/BMP-2, a cytokine that promotes
bone formation, but also is associated with potential
adverse clinical effects including cyst-like bone forma-
tion, soft tissue swelling, and other anabolic activities in
normal and osteoarthritic chondrocytes [14, 15]. Thus,
the aim of the present study was to investigate the asso-
ciation between CXCL-16, BMP-2, and IL-17 plasma
levels and overweight and obese conditions in middle-
aged (35 to 55 years of age) and elderly (>60 years old)




We performed this study using 46 healthy individuals (23
middle-aged and 23 elderly), 33 overweight individuals (20
middle-aged and 13 elderly), and 38 obese individuals (23
middle-aged and 15 elderly). All study participants were of
the female sex and recruited at the UNIMED Inconfi-
dentes, Ouro Preto, MG, Brazil. These women were
undergoing a complete clinical examination and the fol-
lowing laboratory workup was performed: full blood
count, free T4, TSH, glucose, cholesterol, VLDL, LDL,
HDL, and triglycerides. Individuals with hypertension, dia-
betes, thyroid or renal disturbances, or any other cardiac
or systemic diseases as well as those using steroidal drugs
were excluded from this study. These conditions could
prevent adequate interpretation of the association between
obesity-related diseases and immune parameters. After
blood collection and full clinical evaluation, all individuals
were monitored weekly by health professionals (medical
doctors, nutritionists, physiotherapist, and others) from
UNIMED-Inconfidentes.
Definition of anthropometric measures
All study participants had body mass, triceps skinfold,
and arm, waist, and hip circumference measurements
collected by a trained staff member, in accordance with
standardized protocols [16, 17]. Body mass index was
calculated as weight divided by squared height (kg/m2).
The triceps skinfold was verified on the mid-line of the
posterior surface of the arm (over the triceps muscle) at
the level of the mid-point between the acromiale and the
radiale. The subscapular skinfold was measured just
below the angle of the scapula. Waist circumference was
also measured at the midpoint between the lowest rib
and the iliac crest.
Arm muscle circumference was the chosen indicator
for elderly individuals, as the Third National Health and
Nutrition Examination Survey (NHANES III) has
presented reference data for this indicator [18]. All mea-
surements were taken in a private room and conducted
by an experienced nutritionist.
Biochemical analysis
Blood samples (7 ml) were drawn using S-Monovette
tubes (Sarstedt Ltda, Nümbrecht Germany) between
7:00 and 9:00 AM, from all study participants after 12–
14 h of overnight fasting. All blood tests (cholesterol,
VLDL, LDL, HDL, triglycerides, and glycemia) were
performed using conventional enzymatic methods at the
certified Clinical Analysis Laboratory from the Pharmacy
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School at Universidade Federal de Ouro Preto, MG,
Brazil, on the day of blood collection.
Immunoassays for inflammatory mediators
Circulating levels of the inflammatory mediators, IL-17,
CXCL16, and BMP-2, were detected in plasma samples
that were previously stored at −80°C. Briefly, flat-bottom
96-well microtiter plates (Nunc) were coated with 100
μl/well of appropriate monoclonal antibodies for 18 h at
4°C and then washed with PBS buffer (pH 7.4) contain-
ing 0.05% tween-20 (wash buffer). Non-specific binding
sites were blocked with 200 μl/well of 1% bovine serum
albumin in PBS. Plates were washed and 100 μl/well of
sample was added, which was followed by incubation for
18 h at 4°C. In addition, 100 μl/well of the appropriate
biotinylated detection antibody, diluted in blocking buf-
fer containing 0.05% tween-20, was added and samples
were incubated for 1 h at 24°C. Streptavidin-horseradish
peroxidase was added and after subsequent incubation
and washing, 100 μl/well of the chromogen substrate o-
phenylenediamine (Sigma-Aldrich Brasil Ltda, SP,
Brazil), diluted in 0.03 M citrate buffer containing 0.02%
of H2O2 was added for 30 min, which was followed by
incubation in the dark at room temperature. The reac-
tion was stopped through the addition of 50 μl/well of 1
M H2SO4 solution and plates were read at 492 nm in a
spectrophotometer (Emax_Molecular Devices, Sunny-
vale, CA, USA). All samples were simultaneously mea-
sured using Peprotech ELISA kits (Ribeirão Preto, SP,
Brazil) in triplicate.
Statistical analysis
Graph Pad InStat and Prism statistical programs were
used for analysis (GraphPad, San Diego, CA, USA). In
cases of normal distribution, the independent t test
was used, whereas the non-parametric Mann-Whitney
test was used for non-Gaussian sample distributions.
Correlations were verified using a Spearman test and
results were confirmed by performing a linear
regression test. Data were considered statistically sig-
nificant when p < 0.05.
Results
Anthropometric characterization of subjects
Our study population consisted of 63 middle-aged
(mean age of 40.9 years) and 54 elderly (mean age of
68.9 years) women, categorized according anthropomet-
ric parameters as eutrophic, overweight, and obese
(Table 1). All anthropometric parameters such as body
mass, triceps skinfold, arm circumference, arm muscle
circumference, and waist and hip measurements were
elevated in overweight or obese middle-aged and elderly
individuals when compared to eutrophic individuals.
Body mass index similarly increased with weight gain in
both age groups, but the waist-to-hip ratio only increased
in obese middle-aged individuals, and not in overweight
or obese elderly individuals (data not shown).
An apparent reduction in immune and physiological
activity in the senescent body was observed under nat-
ural conditions and without the presence of disease.
Overweight and obese middle-aged individuals presented
with anthropometric parameters that were worse than
those in elderly eutrophic individuals, based on all ana-
lyzed parameters, except for arm muscle circumference.
In addition, overweight and obese conditions were
associated with similar anthropometric parameters, in
both groups of women, with a minimum age difference
of 30 years.
Cholesterol and glucose parameters in overweight and
obese women
Blood biochemical parameters are shown in Table 2.
VLDL cholesterol and glycemia levels were higher in
eutrophic elderly individuals than in eutrophic middle-
aged individuals.
However, when anthropometric parameters were taken
into consideration for this biochemical analysis, over-
weight and/or obese individuals had total cholesterol,
Table 1 Baseline anthropometric parameters of the eutrophic, overweight and obesity subjects
Eutrophic Overweight Obesity
Adult (n = 23) / Elderly (n = 23) Adult (n = 20) / Elderly (n = 13) Adult (n = 23) / Elderly (n = 15)
Age 40,0 ± 1,2 / 71,5 ± 1,4 40,1 ± 1,5 / 64,0 ± 2,0 42,6 ± 1,5 / 71,4 ± 2,1
Body mass (kg) 57,3 ± 1,6 / 59,1 ± 1,6 68,8 ± 1,0* / 70,7 ± 2,1* 86,8 ± 2,6*# / 80,3 ± 1,6*A#
BMI (Kg/m2) 21,8 ± 0,4 / 23,6 ± 0,4 27,2 ± 0,2* / 28,26 ± 0,3* 34,0 ± 0,6*# / 33,2 ± 0,5*#
TSF (mm) 17,0 ± 1,1 / 18,4 ± 1,4 25,8 ± 1,3* / 24,0 ± 1,4 32,2 ± 1,5*# / 28,3 ± 1,5*
AC (cm) 27,1 ± 0,5 / 29,2 ± 0,5 31,3 ± 0,4* / 33,2 ± 0,6* 36,4 ± 0,7*# / 35,5 ± 0,6*
AMC (cm) 21,7 ± 0,5 / 23,4 ± 0,3 23,2 ± 0,4 / 25,7 ± 0,5*A 26,0 ± 0,5*# / 26,8 ± 0,5*
Waist (cm) 82,1 ± 1,6 / 87,1 ± 1,9 91,5 ± 1,5* / 101,1 ± 2,2*A 107,7 ± 2,4*# / 102,9 ± 1,7*
Values are shown as the mean ± SEM. BMI body mass index, TSF Triceps skinfold, AC arm circumference, AMC arm muscle circumference. * p < 0.01 when
eutrophic groups were compared with their respective chronological overweight (OW) or obesity (OB) groups; A p < 0.05 when adult and elderly were compared
among in terms of eutrophic, OW or OB; # P < 0.01 when OW were compared with OB inside the same chronological groups
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VDLL cholesterol, and glycemia levels that were
higher than those in the respective age-matched eu-
trophic control groups. When we compared over-
weight and obese statuses, obese middle-aged
individuals had higher total cholesterol, VLDL, LDL,
HDL, triglycerides, and glycemia levels, whereas only
HDL and triglycerides were different in the obese eld-
erly group.
Interestingly, soluble CXCL16, but not IL-17 and BMP-
2, was positively correlated with glycemia in middle-aged
(r = 0.734, p < 0.01) and elderly (r = 0.604, p < 0.05) indi-
viduals, as well as with VLDL cholesterol in middle-aged
(r = 0.623, p < 0.05) and elderly (r = 0.546, p < 0.05)
individuals.
Plasma indicators of overweight and obesity
Plasma levels of the inflammatory chemokine CXCL16
(Fig. 1a) were markedly elevated in overweight and obese
middle-aged and elderly individuals when compared to
that in eutrophic individuals In addition, CXCL16 was
capable of distinguishing overweight and obese individ-
uals in the two age-related groups. CXCL16 production
in overweight or obese middle-aged individuals was
higher than that observed in 60-year old eutrophic
individuals.
IL-17 (Fig. 1b) production was high in all over-
weight and obese individuals. However, obese elderly
individuals presented with higher cytokine levels than
overweight individuals of the same age group. In
terms of IL-17 production, there were no differences
between overweight and obese middle-aged and eu-
trophic elderly individuals.
BMP-2 (Fig. 1c) was higher in all overweight and obese
middle-aged individuals, similar to that observed with
the Il-17 pattern, but there was no difference observed
between eutrophic and overweight elderly individuals.
Increased production of this factor was observed in
eutrophic and obese elderly individuals, suggesting
natural degeneration of the bones.
Correlations among CXCL16, IL-17, and BMP-2 and anthropo-
metric parameters
We assumed that body mass index, triceps skinfold, arm
muscle circumference, and hip and waist circumferences
are variables used to predict obesity-related comorbidi-
ties. The correlations among these anthropometric
Fig. 1 Concentrations of the CXCL16, IL17 and BMP-2 plasma in
middle-aged adult and elderly women. The concentrations (pg/ml)
of chemokine CXCL16 plasma (a) The bone morphogenetic protein
(BMP-2) (b) the inteleukin-17 (IL-17) (c) from middle-aged adult and
elderly women presenting eutrophic, overweight and obesity
conditions were measured through ELISA. The individual results
were plotted in the graphic through mean ± SEM. # P < 0.05
when all groups were different from the eutrophic middle-aged
adult or elderly subjects
Table 2 Biochemical parameters in eutrophic, overweight and obesity women
Eutrophic Overweight Obesity
Adult (n = 23) / Elderly (n = 23) Adult (n = 20) / Elderly (n = 13) Adult (n = 23) / Elderly (n = 15)
Cholesterol (mg/dL) 157,8 ± 6,5 / 211,0 ± 12,0A 194,0 ± 9,3* / 193,8 ± 13,0 217,0 ± 8,4* “/ 195,9 ± 11,0
VLDL (mg/dL) 13,4 ± 1,0 / 18,8 ± 2,1A 17,9 ± 2,8 / 27,05 ± 1,8A * 22,0 ± 2,3* “/ 28,1 ± 2,9A *
LDL (mg/dL) 125,9 ± 6,1 / 133,0 ± 11,0A 119,9 ± 8,5 / 121,3 ± 12,1 143,2 ± 7,7“/ 125,8 ± 11,6
HDL (mg/dL) 58,3 ± 1,8 / 55,7 ± 2,3 53,6 ± 2,7 / 54,7 ± 3.2 51,5 ± 2,2“/ 46,5 ± 2,1“
Triglycerides (mg/dL) 67,5 ± 5,1 / 86,9 ± 10,6A 89,5 ± 14,0 / 85,6 ± 9,1 111,4 ± 11,5“/ 115,1 ± 10,9“
Glycemia (mg/dL) 91,0 ± 1,9 / 103,2 ± 9,3A 91,3 ± 1,8 / 119,6 ± 8,8A * 104,4 ± 4,7* “/ 117,5 ± 11,9A *
Values are shown as the mean ± SEM. VLDL very low density lipoproteins, LDL low density lipoproteins, HDL High density lipoproteins. Statistical differences are
represented being that (*) p < 0.05 when the OW or OB were compared with the eutrophic individuals in the same age group; (Δ) p < 0.05 when adult and elderly
were compared in the same anthropometric group, (∞) when OB is different from OW in the same age group
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parameters and plasma CXCL16, BMP-2, and IL-17
levels are shown in Table 3. Accordingly, CXCL16
showed the highest correlation with body mass index,
triceps skinfold, and waist and hip circumference in
middle-aged and elderly individuals, with Pearson’s
correlation coefficients (r) > 0.5.
Finally, IL-17 plasma levels were also positively corre-
lated with body mass index, arm muscle circumference,
and hip and waist circumferences in both age-related
groups, whereas BMP-2 levels were only correlated with
these anthropometric parameters in the elderly group.
Discussion
Results presented herein highlight the potential for
CXCL16, IL-17, and BMP-2 plasma levels to be used as
marker to discriminate overweight and obese individuals
in both age groups. In particular, production of the che-
mokine CXCL16 was markedly high in the overweight
and obese groups, and this correlated with anthropomet-
ric parameters that are considered comorbidity predictors.
The identification of biomarkers to predict obesity has
become in important research area within the basic and
clinical sciences, owing to the ability of these factors to
predict cardiovascular and metabolic disturbances; this
allows for proper treatment and lifestyle changes in indi-
viduals [19]. Unfortunately, the underlying complexity of
biological pathway interactions demands further re-
search before any of these potential biomarkers can be
accurately used for diagnostic purposes. Many cellular
inflammatory mediators come from white fat tissues,
and they are often overproduced because of increased
adiposity. In contrast, other regulatory factors or media-
tors of insulin sensitivity, such as adiponectin, are found
in smaller amounts in similar conditions [20]. This
imbalance between adipocyte products and other inflam-
matory mediators, caused by overweight and obese con-
ditions might promote obesity-linked metabolic and
cardiovascular disorders [1, 9]. Therefore, investigating
biomarkers in overweight individuals should be a more
common procedure in research and clinic. Ordinary in-
dividuals naturally gain a small amount of weight within
a certain period-of-time; however, continuous chronic
weight gain becomes problematic.
Interestingly, CXCL16 was shown to have a strong and
exclusive association with overweight and obese condi-
tions, regardless of subject age. Elderly women with
higher VLDL and glycemia typically had higher levels of
circulating CXCL16; these high circulating levels have
previously been associated with the development of
plaque deposits, artery walls, and/or diabetes [18, 20,
21]. Anthropometric parameters such as body mass
index, triceps skinfold, and waist and hip circumference
were positively correlated with CXCL16 levels in
middle-aged and elderly women. CXCL16 is expressed
in macrophages and aortic muscle cells. Expression
increases in response to inflammatory stimuli and this
enhances LDL uptake in favor of foam cell formation in
human atherosclerotic plaques [11, 13]. Some chemokines
have been described as effective adipokines and as bio-
markers of obese conditions because of their inflamma-
tory profile, which is associated with weight gain and
adipose tissue accumulation, and the fact that their recep-
tors are overexpressed in subcutaneous and visceral adi-
pose tissues of obese individuals [22]. Previous studies
have indicated an association between CXCL16 and obes-
ity in C57BL6 mice [23] and coronary comorbidities in
humans [24–26]. By assuming that obesity predisposes in-
dividuals to coronary and metabolic diseases, the present
Table 3 Correlation among CXCL16, IL-17 and BMP-2 and anthropometric parameters
ADULTS BMI TSF AMC WAIST HIP WHR
CXCL16 R = 0.798* R = 0,552* R = 0.119 R = 0.860* R = 0.555* R = 0.2081
p = 0.023 p = 0.5521 p = 0.1981 p = 0.016 p = 0.050 p = 0 . 1 9 8 1
IL-17 R = 0.188* R = 0.354 R = 0.371* R = 0.341 R = 0.556* R = 0.221*
p = 0.047 p = 0.850 p = 0.010 p = 0.117 p = 0.050 p = 0.014
BMP-2 R = 0.1629 R = 0.0935 R = 0.1778 R = 0.2423 R = 0.1518 R = 0.1778
p = 0.1034 p = 0,3523 p = 0.0752 p = 0.0146 p = 0.1295 p = 0.075
ELDERLY BMI TSF AMC WAIST HIP WHR
CXCL16 R = 0.798* R = 0.552* R = 0.198 R = 0.860* R = 0.555* R = 0.198
p = 0.020 p = 0.050 p = 0.119 p = 0.016 p = 0.050 p = 0 . 1 1 0
IL-17 R = 0.184* R = 0.332 R = 0.227* R = 0.146 R = 0.542* R = 0.371*
p = 0.030 p = 0.090 p = 0.014 p = 0.110 p = 0.050 p = 0.020
BMP-2 R = 0.179* R = 0.352 R = 0.187* R = 0.242* R = 0.251 R = 0.188*
p = 0.050 p = 0,090 p = 0.050 p = 0.014 p = 0.129 p = 0.050
BMI body mass index, TSF triceps skinfold, AMC arm muscle circumference, WHR waist-to-hip ratio
* positive correlation with p < 0.05
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study included overweight and obese women. Regardless
of this, high plasma levels of CXCL16 were observed in all
middle-aged and elderly individuals presenting with an an-
thropometric status above overweight.
Overweight or obese individuals were expected to have
increased adipocyte numbers, resulting from the recruit-
ment of pluripotent stem cells to the vascular stroma of
adipose tissue [27]. In our study, BMP-2 was investigated
and was shown to be clearly elevated in overweight and
obese middle-aged and elderly individuals. Regarding
anthropometric parameters, this factor was positively cor-
related with body mass index, arm muscle circumference,
and waist and waist-to-hip ratio in elderly women. These
parameters are indicative of overweight or obese condi-
tions, reinforcing the potential role BMP-2 to categorize
individuals according to metabolic status. BMP-2 has been
shown to promote osteogenic differentiation and adipo-
genesis in bone marrow stromal cells [28], and it could be
partially responsible for increased obesity. A recent study
suggested that increased demand to store excessive energy
promotes BMP-2 expression and that adipocytes contrib-
ute to this phenomenon, due to energy storage in visceral
and subcutaneous adipose tissues [29]. The present study
reinforces such findings, since increased BMP-2 levels
were observed in overweight and obese women and were
associated with anthropometric parameters that indicate
adipose tissue accumulation.
Unlike BMP-2, IL-17 has emerged as a negative regulator
of adipogenesis and glucose metabolism in an experimental
model. This cytokine acts in a complex network of inflam-
matory mediators that links adipose tissue to inflammatory
cells such as neutrophils and adipocytes [10, 30, 31]. Indeed,
excessive production of IL-17 during the initial stage of
obesity could have a different effect on maintaining a pro-
longed inflammatory response and on associated long-term
consequences. IL-17 was remarkably high in elderly individ-
uals, and particularly in the obese and overweight middle-
aged individuals; here, higher levels of VLDL and glycemia
were observed. In addition, IL-17 was also positively corre-
lated with classical anthropometric parameters (body mass
index, arm muscle circumference, and hip and waist-to-hip
ratio). These parameters have been described as anthropo-
metric markers of poor prognosis in metabolic and cardio-
vascular diseases [19]. They have also been shown to
contribute to the release of other inflammatory cytokines
such as IL-6, IFN-gamma, and TNF [10], which reinforces
the potential role of IL-17 in obesity-related diseases.
Our data reinforce the fact that obese individuals (mid-
dle-aged and elderly) present with higher cholesterol frac-
tions, triglycerides, and glycemia, when compared to those
parameters in eutrophic individuals, in accordance with the
previous studies [1]. However, these overweight middle-
aged individuals must receive follow-up care from health
professionals when considering the relevance of visceral
obesity, alongside soluble biomarkers. Nonetheless, inte-
grated intervention programs based on weight reduction
are demanding, since the immune conditions (systemic in-
flammation) in these patients are similar to those in elderly
individuals. This might indicate the presence of accelerated
damage due to the production of inflammatory mediators
(e.g. CXCL-16, IL-17, and BMP-2), since high levels of
these circulating factors clearly represent a risk for cardio-
vascular disease, cancer, and metabolic disturbances [12, 19,
25]. Preventing and reducing overweight and obese condi-
tions depends on medical interventions, in addition to indi-
vidual lifestyle changes; however, further research to
motivate behavioral changes is required.
Conclusion
The present study provides complementary information
regarding BMP-2, IL-17, and particularly CXCL-16, and
their potential to be used as soluble markers capable of dif-
ferentiating overweight and obese statuses in middle-aged
and elderly women. These biomarkers were shown to be
correlated with anthropometric (body mass index, triceps
skinfold, arm muscle circumference, and hip and waist
circumference) and biochemical (VLDL and glycemia)
parameters. These factors might alter the inflammation axis
observed in overweight and obese individuals, as well as in
related disorders such as atherosclerosis, insulin resistance,
and vascular damage. However, their clinical application
needs to be investigated further in prospective population
studies since its application in the clinical screening of over-
weight could help early in the preventive management of
diseases associated with obesity.
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